Stockreport

We're Not Very Worried About ArriVent BioPharma's (NASDAQ:AVBP) Cash Burn Rate [Yahoo! Finance]

ArriVent BioPharma, Inc.  (AVBP) 
PDF lost money for years while it grew recurring revenue, if you held shares since 2005, you'd have done very well indeed. But while history lauds those rare successes, thos [Read more]